GO Term | Evidence Code | PMID |
---|---|---|
response to estradiol | ||
peptide antigen assembly with MHC class I protein complex |
GO Term | Evidence Code | PMID |
---|---|---|
nucleus | ||
nuclear envelope | ||
endoplasmic reticulum lumen | ||
MHC class I peptide loading complex | ||
endoplasmic reticulum-Golgi intermediate compartment membrane |
|
GO Term | Evidence Code | PMID |
---|---|---|
DNA binding |
|
|
integrin binding | ||
zinc ion binding |
|
|
nuclear androgen receptor binding | ||
protein folding chaperone |
|
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11678 | onchocerciasis | |
DOID:11729 | Lyme disease | |
DOID:2615 | papilloma | |
DOID:850 | lung disease | |
DOID:0060303 | complement component 9 deficiency | |
DOID:0060319 | cardiac arrest | |
DOID:0040085 | bacterial sepsis | |
DOID:0050387 | nonpapillary renal cell carcinoma | |
DOID:0050424 | familial adenomatous polyposis | |
DOID:0050458 | juvenile myelomonocytic leukemia |
HPO ID | HPO Term |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000505 | Visual impairment |
HP:0000952 | Jaundice |
HP:0000967 | Petechiae |
HP:0000978 | Bruising susceptibility |
HP:0000979 | Purpura |
HP:0000980 | Pallor |
HP:0001028 | Hemangioma |
HP:0001082 | Cholecystitis |
HP:0001394 | Cirrhosis |
Disease ID | Disease Name |
---|---|
ORPHA:824 |
|
OMIM:254450 |
|
ORPHA:3318 |
|
OMIM:187950 |
|
ORPHA:131 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
116830818 | CHEAB16210 | ||
105307175 | PTEVA06322 | ||
105807890 | PROCO20355 | ||
122138234 | CYPCA73364 | ||
103751874 | NANGA16764 | ||
116437044 | CORMO16748 | ||
103249397 | CARSF22641 | ||
115603437 | STRHB06444 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024